The story has been updated with information about the pricing of the notes released by Agilent after the close of the market.

NEW YORK (GenomeWeb News) – Agilent Technologies today announced it is offering a series of senior notes, partly to fund its restructuring initiative and expand its share buyback program.

Separately, Fitch Ratings assigned a BBB+ rating to the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.